
-
British Airways owner unveils big Boeing, Airbus order
-
IPL suspended for one week over India-Pakistan conflict
-
Slot says all at Liverpool sad to see Alexander-Arnold go
-
Leo XIV celebrates first mass as pope in Sistine Chapel
-
India says repulsed fresh Pakistan attacks as death toll climbs
-
Japan's Panasonic targets 10,000 job cuts worldwide
-
Putin evokes WWII victory to rally Russia behind Ukraine offensive
-
China exports beat forecasts ahead of US tariff talks
-
Leo XIV, the 'Latin Yankee', to celebrate first mass as pope
-
Most stocks lifted by hopes for US-China talks after UK deal
-
IPL suspended indefinitely over India-Pakistan conflict: reports
-
German lender Commerzbank's profits jump as it fends off UniCredit
-
Rare bone-eroding disease ruining lives in Kenya's poorest county
-
India says repulsed fresh Pakistan attacks as de-escalation efforts grow
-
Zhao's historic snooker title sparks talk of China world domination
-
'High expectations': EU looks to Merz for boost in tough times
-
Poisoned guests rarely invited before deadly mushroom lunch, Australia trial hears
-
China sales to US slump even as exports beat forecasts
-
Indian cricket to make 'final decision' on IPL over Pakistan conflict
-
Dethroned Bundesliga champions Leverkusen face uncertain future
-
China can play hardball at looming trade talks with US: analysts
-
French monuments in trouble while PSG prepare for Champions League final
-
Newcastle face Chelsea in top five showdown, Alexander-Arnold in spotlight
-
Flick's Barca must show 'hunger' in crunch Liga Clasico
-
Clasico the last chance saloon for Ancelotti's Real Madrid
-
Timberwolves overpower Warriors to level series
-
Chinese fabric exporters anxious for US trade patch-up
-
Putin gears up to host world leaders at lavish army parade
-
Nearing 100, Malaysian ex-PM Mahathir blasts 'old world' Trump
-
Leo XIV, first US pope, to celebrate first mass as pontiff
-
Asian stocks lifted by hopes for US-China talks after UK deal
-
Former head of crypto platform Celsius sentenced 12 years
-
Ex-model testifies in NY court that Weinstein assaulted her at 16
-
Nestlé and OMP Showcase Approach to Future-Ready Supply Chain at Gartner Supply Chain Symposium/Xpo in Barcelona
-
Genflow Biosciences PLC Announces Share Subscription, Director's Dealing and Update
-
Argo Blockchain PLC Announces 2024 Annual Results and Restoration of Listing
-
'Great honor': world leaders welcome first US pope
-
Pacquiao to un-retire and fight Barrios for welterweight title: report
-
Trump unveils UK trade deal, first since tariff blitz
-
Man Utd one step away from Europa League glory despite horror season
-
Jeeno shines on greens to grab LPGA lead at Liberty National
-
Mitchell fires PGA career-low 61 to grab Truist lead
-
AI tool uses selfies to predict biological age and cancer survival
-
Extremely online new pope unafraid to talk politics
-
Postecoglou hits back as Spurs reach Europa League final
-
Chelsea ease into Conference League final against Betis
-
Pope Leo XIV: Soft-spoken American spent decades amid poor in Peru
-
First US pope shared articles critical of Trump, Vance
-
'Inexcusable' - NBA champs Boston in trouble after letting big leads slip
-
US automakers blast Trump's UK trade deal

French inventor of abortion pill calls Wyoming ban 'scandalous'
French scientist Etienne-Emile Baulieu, known as the father of the abortion pill, said it was "scandalous" and "a setback for women's freedom" that the US state of Wyoming has banned the drug.
Baulieu, who at the age of 96 is still working on treatments for depression and Alzheimer's, did not mince his words about the ban.
"It is a setback for women's freedom, particularly for those in the most precarious position who do not have the means to go to another state" to get an abortion, he told AFP in an interview.
Last week Wyoming became the first US state to outlaw the use of the abortion pill.
It was the latest point marked for conservative anti-abortion activists in the United States after the Supreme Court overturned the constitutional right to the procedure last year, leaving the policy to individual states.
Baulieu said he had dedicated a large part of his life to "increasing the freedom of women," and the ban was a step in the opposite direction.
Born in Strasbourg in 1926 to Jewish parents, Baulieu was raised by his feminist mother after his father, a doctor, died when he was a boy. At the age of 15, Baulieu joined the French resistance against Nazi occupation.
He went on to become a self-described "doctor who does science," specialising in the field of steroid hormones.
Invited to work in the United States, Baulieu was noticed in 1961 by Gregory Pincus, known as the father of the contraceptive pill, who convinced him to focus on sex hormones.
Back in France, Baulieu designed a way to block the effect of the hormone progesterone, which is essential for the egg to implant in the uterus after fertilisation.
"I wanted to make a contragestive," which stops gestation, he told AFP.
Partnering with the French Roussel-Uclaf laboratory, the oral drug RU-486, also known as mifepristone, was developed in 1982, providing a safe and inexpensive alternative to surgical abortion.
But there was a long battle for the drug to become authorised in the United States, where anti-abortion activists dubbed it the "death pill".
- 'Fanaticism and ignorance' -
In early March, French President Emmanuel Macron praised Baulieu's resilience when he presented the scientist with the Grand-Croix de la Legion d'Honneur, the top rank in France's honours system.
"You, a Jew and a resistance fighter, you were overwhelmed with the most atrocious insults and even compared to Nazi scientists," Macron said.
"But you held on, for the love of freedom and science."
Baulieu's wife Simone Harari Baulieu, a media producer in France, said "adversity slides off him like water off a duck's back".
She added that the recent "step backwards" in the United States was propelled by "fanaticism and ignorance".
Even at age 96, Baulieu heads into his office at the Kremlin-Bicetre University Hospital in the southern suburbs of Paris three times a week.
Stacks of photos, diplomas and binders contain "the work of a lifetime," the scientist said, adding that he still wants to "be useful".
His latest award is pinned to his blue suit, but Baulieu said he "never seriously hoped to receive such honours".
"It was a pleasure, but what interests me is improving people's health."
- 'Driving force' -
The team in his lab are continuing research he began years ago aiming to prevent the development of Alzheimer's disease, as well as treatment for severe depression, for which clinical trials begin in the coming months.
Baulieu said "there is no reason we cannot find treatments" for both illnesses, which have stubbornly evaded many previous attempts.
Julien Giustiniani, the team leader at the Baulieu Institute, which was created to finance research into dementia, said Baulieu was "always enthusiastic".
"He is a driving force for us," Giustiniani said.
Though Baulieu now uses a cane to walk, he exudes a tireless energy.
He partly credits using DHEA, a natural hormone produced by the adrenal gland, which Baulieu first described in the 1960s and has been touted as an anti-ageing supplement.
The causes that have dominated his life were "women, brain health and longevity," Baulieu said.
"I would be bored if I did not work anymore," he added.
X.Karnes--AMWN